Sci-Tech World Delaware: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech World Delaware.

Press releases published on September 18, 2026

Sep. 18, 2026

NoimosAI Launches Customer Engagement Agent to Automate Behavior-Based Customer Marketing

Indeterminate EIN Presswire

Sep. 18, 2026

Google Workspace Gains Flexible Access Request Automation for the Approvals Identity Providers Don't Cover

Indeterminate EIN Presswire

Sep. 18, 2026

Customer Voice Puts Kissflow at #1 on Gartner Peer Insights ahead of Salesforce, Appian and Outsystems

Indeterminate EIN Presswire

Sep. 18, 2026

BIBLIOJAM ANNOUNCES APP THAT TURNS THE ENTIRE BIBLE INTO A YEARLONG MUSICAL EXPERIENCE

Indeterminate GlobeNewswire

Sep. 18, 2026

CT UAV Successfully Designs 230 kg Heavy-Lift Transport UAV, Capable of Carrying 100 kg

Indeterminate GlobeNewswire

Sep. 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Amplified 2026 Returns September 24: The World's Biggest Free Online Event for Print-on-Demand Sellers

Indeterminate EIN Presswire

Sep. 18, 2026

Bastion Receives Conditional OCC Approval for a National Trust Bank Charter

Indeterminate GlobeNewswire

Sep. 18, 2026

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire

Sep. 18, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Indeterminate GlobeNewswire

Sep. 18, 2026

Mark Cuban Foundation and SL2 Bring Free AI Bootcamp to Boston Teens

Indeterminate GlobeNewswire

Sep. 18, 2026

Optimum7 Documents a Custom Product Configurator for a Mattress Catalog Beyond Native Shopify and BigCommerce Variants

Indeterminate GlobeNewswire

Sep. 18, 2026

SodaMelt Capsules Introduces Soda Melt Multi-Ingredient Dietary Supplement for Metabolic Wellness

Indeterminate GlobeNewswire

Sep. 18, 2026

HoneyPower Capsules Introduces Honey Power Multi-Ingredient Dietary Supplement for Male Enhancement

Indeterminate GlobeNewswire